Deyali Chatterjee Selected Research

Neoplasms (Cancer)

5/2024	The modern face of esophageal candidiasis in an oncology center: Correlating clinical manifestations, endoscopic grade, and pathological data in 323 contemporary cancer patients.
8/2023	Tuberous sclerosis complex mutations in patients with pancreatic neuroendocrine tumors. Observations on phenotypic and treatment-related associations.
6/2023	Comparative Analyses of the Clinicopathologic Features of Short-Term and Long-Term Survivors of Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreatoduodenectomy.
5/2023	Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and Pancreatectomy.
1/2023	Epithelial SOX9 drives progression and metastases of gastric adenocarcinoma by promoting immunosuppressive tumour microenvironment.
9/2022	Imaging Features of Premalignant Biliary Lesions and Predisposing Conditions with Pathologic Correlation.
6/2022	Histo-molecular characterization of pancreatic cancer with microsatellite instability: intra-tumor heterogeneity, B2M inactivation, and the importance of metastatic sites.
1/2022	Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer.
10/2021	Clinical Calculator Based on Molecular and Clinicopathologic Characteristics Predicts Recurrence Following Resection of Stage I-III Colon Cancer.
1/2021	Single institutional experience on primary neuroendocrine neoplasms of the kidney: a rare distinct entity.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Deyali Chatterjee Research Topics

Disease

33	Neoplasms (Cancer) 05/2024 - 01/2012
23	Adenocarcinoma 06/2023 - 03/2012
7	Pancreatic Neoplasms (Pancreatic Cancer) 12/2022 - 04/2014
4	Neoplasm Metastasis (Metastasis) 01/2023 - 09/2015
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2023 - 01/2017
3	Lymphatic Metastasis 05/2023 - 01/2015
3	Residual Neoplasm 12/2022 - 06/2012
3	Lung Neoplasms (Lung Cancer) 02/2019 - 08/2012
2	Hyperplasia 01/2023 - 01/2022
2	Microsatellite Instability 06/2022 - 01/2021
2	Insulinoma 10/2020 - 10/2019
2	Fibrosis (Cirrhosis) 01/2020 - 12/2013
2	Carcinoma (Carcinomatosis) 01/2019 - 06/2012
2	Inflammation (Inflammations) 01/2017 - 12/2013
2	Carcinogenesis 12/2013 - 02/2013
1	Candidiasis (Moniliasis) 05/2024
1	Esophageal Diseases 05/2024
1	Necrosis 06/2023
1	Acute Cholecystitis 06/2023
1	Hemorrhage 06/2023
1	Leukoencephalopathies 01/2023
1	Neuroendocrine Carcinoma 01/2023
1	Ascites 01/2023
1	Pancreaticobiliary Maljunction 09/2022
1	Carcinoma in Situ 09/2022
1	Abdominal Pain (Pain, Abdominal) 09/2022
1	Choledochal Cyst (Choledochal Cysts) 09/2022
1	Sclerosing Cholangitis 09/2022
1	Parasitic Diseases (Parasitic Disease) 09/2022
1	Glandular and Epithelial Neoplasms (Neoplasms, Glandular) 09/2022
1	Rectal Neoplasms (Rectal Cancer) 07/2021
1	Sarcoidosis (Schaumann Disease) 01/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2021
1	Pathologic Complete Response 04/2020
1	Tics (Tic) 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 11/2019
1	Chemical and Drug Induced Liver Injury 02/2019
1	Adenocarcinoma of Lung 02/2019
1	Cholecystitis 01/2019
1	Non-alcoholic Fatty Liver Disease 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 06/2015
1	Disease Progression 12/2014
1	Hypoxia (Hypoxemia) 12/2014

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 10/2020 - 08/2012
4	N-acetyltalosaminuronic acid (NAT)IBA 06/2023 - 11/2018
3	Gemcitabine FDA Link 05/2023 - 04/2014
2	Eosine Yellowish-(YS) (Eosin)IBA 12/2022 - 01/2019
2	Dental Porcelain (Porcelain)IBA 09/2022 - 01/2019
2	SynaptophysinIBA 01/2021 - 10/2019
2	Transcription Factors (Transcription Factor)IBA 10/2020 - 10/2019
2	ErbB Receptors (EGF Receptor)IBA 02/2019 - 09/2015
2	LumicanIBA 10/2016 - 12/2014
2	DNA (Deoxyribonucleic Acid)IBA 11/2014 - 04/2014
1	Fluconazole (Zonal)FDA LinkGeneric 05/2024
1	AzolesIBA 05/2024
1	trans-sodium crocetinate (crocetin)IBA 08/2023
1	130-nm albumin-bound paclitaxelIBA 05/2023
1	folfirinoxIBA 05/2023
1	Retinaldehyde (Retinal)IBA 01/2023
1	Alkaline PhosphataseIBA 01/2023
1	Exonucleases (3' 5' Exonuclease)IBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	NectinsIBA 01/2022
1	Proton Pump InhibitorsIBA 01/2022
1	ChromograninsIBA 01/2021
1	Hemoglobins (Hemoglobin)IBA 11/2019
1	RadonIBA 11/2019
1	Chromogranin AIBA 10/2019
1	Tyrosine Kinase InhibitorsIBA 02/2019
1	osimertinibIBA 02/2019
1	Hematoxylin (Haematoxylon)IBA 01/2019
1	Bile Acids and Salts (Bile Acids)IBA 01/2019
1	Lipocalin-2IBA 01/2017
1	CollagenIBA 10/2016
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2016
1	Capecitabine (Xeloda)FDA Link 01/2016
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2016
1	Bevacizumab (Avastin)FDA Link 01/2016
1	AT 61IBA 01/2016
1	Somatomedin Receptors (Somatomedin Receptor)IBA 09/2015
1	Coal (Coals)IBA 01/2015
1	Glucose (Dextrose)FDA LinkGeneric 12/2014
1	Lactic Acid (Lactate)FDA LinkGeneric 12/2014
1	Adenosine Triphosphate (ATP)IBA 12/2014
1	Cyclin D1IBA 05/2014
1	Nucleoside Transport Proteins (Nucleoside Transporter)IBA 04/2014
1	Phosphotransferases (Kinase)IBA 12/2013
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2013
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2013
1	TensinsIBA 11/2013

Therapy/Procedure

13	Neoadjuvant Therapy 06/2023 - 04/2012
12	Therapeutics 05/2023 - 11/2014
8	Pancreaticoduodenectomy 06/2023 - 03/2012
4	Cholecystectomy 06/2023 - 01/2019
3	Immunotherapy 06/2022 - 01/2021
2	Pancreatectomy 05/2023 - 01/2020
2	Drug Therapy (Chemotherapy) 11/2018 - 04/2014
1	Colectomy 10/2021
1	Adjuvant Chemotherapy 10/2021
1	Radiotherapy 01/2016